The GLP is committed to full transparency. Download and review our just-released 2019 Annual Report.

3 ways artificial intelligence is tackling cancer

Case Study 1: The Sharing Project

[Jinghui Zhang wondered] how much faster cancer research could move if data sets were freely and immediately available to computational biologists who wanted to work on them, so in April she partnered with Microsoft to release St. Jude Cloud, a web-based data processor that offers access—within 48 hours—to the largest publicly available set of childhood cancer stats in the world, the whole genomes of more than 5,000 St. Jude patients.

Case Study 2: Machine Learning for Doctors

In January 2018, Microsoft also partnered with the charity Stand Up to Cancer on an $11 million research program called Convergence 2.0 to solve a problem that is essentially the reverse of the one Zhang faced: researchers who have data sets or ideas worth studying, but little or no computer programming expertise.

Related article:  First Mars, then Jupiter's moons: How artificial intelligence is ramping up space exploration

Convergence 2.0 funded seven teams of researchers and medical doctors, matching each with machine-learning experts from places like Microsoft and MIT.

Case Study 3: Sharable Tumor Samples

Meanwhile, for clinicians, a new company called Paige.AI made an agreement with Memorial Sloan Kettering Cancer Center in New York to train machine-learning algorithms on its absolutely massive collection of 25 million digitized tumor slides. The software will eventually be able to help doctors all over the country diagnose cancer from biopsies the same way a top MSK pathologist would.

Read full, original post: Cancer Has a New Enemy: A.I.

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend